These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6724463)

  • 21. Medicine Adverse Reactions Committee: eighteenth annual report, 1983.
    Edwards IR
    N Z Med J; 1984 Oct; 97(766):729-32. PubMed ID: 6239993
    [No Abstract]   [Full Text] [Related]  

  • 22. [Modification of the prescribing practice of the physician by decisions of drug committees, specialty groups and consensus conferences].
    Müller-Oerlinghausen B
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):606-10. PubMed ID: 9527451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reportable cases of adverse effects of drugs in the period from 1 May to 31 July 1968].
    Ugeskr Laeger; 1968 Oct; 130(40):1672-6. PubMed ID: 5701591
    [No Abstract]   [Full Text] [Related]  

  • 24. [Adverse or toxic effects of drugs in medical practice: a one-year follow-up].
    Grange JC
    Therapie; 1990; 45(4):331-4. PubMed ID: 2399517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug-induced blood dyscrasias. Reports to the Committee on Adverse Drug Reactions 1968-1983].
    Jennum P; Kristensen MB
    Ugeskr Laeger; 1985 Aug; 147(32):2539-41. PubMed ID: 4060328
    [No Abstract]   [Full Text] [Related]  

  • 27. [Detection and reporting of adverse reaction to drugs].
    Domínguez Carmona M
    Rev Sanid Hig Publica (Madr); 1978; 52(5-6):563-625. PubMed ID: 746332
    [No Abstract]   [Full Text] [Related]  

  • 28. New Zealand Committee on Adverse Drug Reactions: thirteenth annual report, 1978.
    McQueen EG
    N Z Dent J; 1979 Jul; 75(341):162-7. PubMed ID: 293539
    [No Abstract]   [Full Text] [Related]  

  • 29. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001.
    Kimland E; Rane A; Ufer M; Panagiotidis G
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):493-9. PubMed ID: 15918163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse drug reactions and the P & T committee.
    Lipman AG
    Hosp Formul; 1980 Jul; 15(7):580. PubMed ID: 10247654
    [No Abstract]   [Full Text] [Related]  

  • 32. Adverse Drug Reactions Advisory Committee report for 1973.
    Med J Aust; 1974 Dec; 2(24):875-80. PubMed ID: 4156076
    [No Abstract]   [Full Text] [Related]  

  • 33. Increasing threat to man as a result of frequently uncontrolled and widespread use of various drugs.
    Venulet J
    Int J Clin Pharmacol Biopharm; 1975 Dec; 12(4):387-94. PubMed ID: 1205653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adverse drug reactions in a surgical department].
    Andersen T; Nielsen IK; Christiansen LV; Folkenberg F; Osterlind AW; Olsen L; Christau S; Kampmann JP; Hansen JM
    Ugeskr Laeger; 1978 Apr; 140(14):799-802. PubMed ID: 644670
    [No Abstract]   [Full Text] [Related]  

  • 35. [Registration of drug adverse effects and complications in 1970-1971].
    Skobba TJ; Lunde PK
    Tidsskr Nor Laegeforen; 1972 Aug; 92(24):1537-40. PubMed ID: 5076543
    [No Abstract]   [Full Text] [Related]  

  • 36. Adverse drug effects: evaluation of four secondary reference sources.
    Lyon RA
    Hosp Formul; 1985 Mar; 20(3):315-7, 320-1. PubMed ID: 10270307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Zealand Committee on Adverse Drug Reactions. Eighth annual report.
    N Z Med J; 1973 Oct; 79(500):309-16. PubMed ID: 4519120
    [No Abstract]   [Full Text] [Related]  

  • 38. [Bullous drug exanthemata with special regard to toxic epidermal necrolysis (Lyell)].
    Jánoska A; Sinka L
    Cesk Dermatol; 1969 Oct; 44(5):211-7. PubMed ID: 5361844
    [No Abstract]   [Full Text] [Related]  

  • 39. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective.
    Wright C; Schnoll S; Bernstein D
    Ann N Y Acad Sci; 2008 Oct; 1141():284-303. PubMed ID: 18991964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.